Study of vancomycin susceptibility in methicillin-resistant Staphylococcus aureus isolated from clinical samples

被引:7
作者
Sharma, Prajna [1 ]
Vishwanath, G. [2 ]
机构
[1] AJ Inst Med Sci, Dept Microbiol, Mangalore, India
[2] JJM Med Coll, Davangere, India
关键词
Methicillin-resistant Staphylococcus aureus; minimum inhibitory concentration; vancomycin intermediate Staphylococcus aureus/vancomycin resistant Staphylococcus aureus;
D O I
10.4103/1755-6783.98609
中图分类号
R188.11 [热带医学];
学科分类号
摘要
Background : Staphylococcus aureus is one of the most commonly isolated organisms in nosocomial infections. While the prevalence of methicillin--resistant Staphylococcus aureus (MRSA) continues to increase worldwide, there is a concern about an increase in vancomycin minimum inhibitory concentrations (MIC,s) among S. aureus strains. An attempt was, therefore, made to study vancomycin susceptibility in 156 MRSA isolates from various clinical samples during the period of February 2008 to January 2009. Materials and Methods: A total of 156 isolates of S. aureus were collected from various clinical specimens. MIC of vancomycin was detected by agar dilution method. Results : Out of 156 MRSA isolates all were susceptible to vancomycin by disc diffusion method. By agar dilution method, 138 isolates were susceptible to vancomycin (VISA MIC 0.5-2 mu gm/ml) and 18 isolates showed intermediate susceptibility to vancomycin (VISA MIC 4-8 mu gm/ml). No vancomycin resistant S. aureus (VRSA) with MIC >= 16 mu gm/ml was detected. Conclusion : The present study reveals the emergence of MRSA with reduced susceptibility to vancomycin and indicates the magnitude of antibiotic resistance in and around Davangere.
引用
收藏
页码:178 / 180
页数:3
相关论文
共 12 条
  • [1] [Anonymous], 2007, CLIN INFECT DIS, V44, P1208
  • [2] [Anonymous], 2000, NCLS
  • [3] Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA)
    Appelbaum, Peter C.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 30 (05) : 398 - 408
  • [4] Assadullah S, 2003, Indian J Med Microbiol, V21, P196
  • [5] Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, P624
  • [6] Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P565
  • [7] Emergence of vancomycin resistance in Staphylococcus aureus
    Smith, TL
    Pearson, ML
    Wilcox, KR
    Cruz, C
    Lancaster, MV
    Robinson-Dunn, B
    Tenover, FC
    Zervos, MJ
    Band, JD
    White, E
    Jarvis, WR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (07) : 493 - 501
  • [8] Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin
    Song, JH
    Hiramatsu, K
    Suh, JY
    Ko, KS
    Ito, T
    Kapi, M
    Kiem, S
    Kim, YS
    Won, SH
    Peck, KR
    Lee, NY
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) : 4926 - 4928
  • [9] Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides
    Tenover, FC
    Lancaster, MV
    Hill, BC
    Steward, CD
    Stocker, SA
    Hancock, GA
    O'Hara, CM
    Clark, NC
    Hiramatsu, K
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (04) : 1020 - 1027
  • [10] Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India
    Tiwari, Hare Krishna
    Sen, Malay Ranjan
    [J]. BMC INFECTIOUS DISEASES, 2006, 6 (1)